Virtual Medicinal Product (VMP)
-
Blinatumomab 38.5micrograms powder for solution for infusion vials
Name Details
Current Name
Blinatumomab 38.5micrograms powder for solution for infusion vials
|
Start Date
23-12-2015
|
End Date
|
Previous Name
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials
|
Start Date
18-12-2015
|
End Date
22-12-2015
|
|
Abbreviated Name
Blinatumomab 38.5micrograms inf vials
|
Start Date
18-12-2015
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01FX07
SNOMED Codes
Code
|
Start Date
|
End Date
|
31143811000001101 |
18-12-2015 |
|
VMP Ingredients
VMP ingredients table
Blinatumomab |
Based on Ingredient Substance |
|
38.5 microgram |
|
Name
Blinatumomab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
38.5
Strength and UOM (Dmr)
Parent Products
-
VTM
Blinatumomab
-
VMP
(Current) Blinatumomab 38.5micrograms powder f...
Virtual Medicinal Product Pack (VMPP) Information